Frequency and hemostatic abnormalities in pre-DIC patients

Thrombosis Research

Volumn 126, Issue 1, 2010, Pages 74-78

  Okamoto, Kohji ^a   Wada, Hideo ^b   Hatada, Tsuyoshi ^b   Uchiyama, Toshimasa ^c   Kawasugi, Kazuo ^d   Mayumi, Toshihiko ^e   Gando, Satoshi ^f   Kushimoto, Shigeki ^g   Seki, Yoshinobu ^h   Madoiwa, Seiji ⁱ   Asakura, Hidesaku ^j   Koga, Shin ^k   Iba, Toshiaki ^l   Maruyama, Ikuro ^m  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c National Hospital Organization   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h Niigata Prefectural Shibata Hospital   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j KANAZAWA UNIVERSITY   (Japan)

^k UNIVERSITY OF SHIZUOKA   (Japan)

^l JUNTENDO UNIVERSITY   (Japan)

^m KAGOSHIMA UNIVERSITY   (Japan)

more..

Author keywords

DIC; Hemostatic markers; Mortality; Pre DIC; Resolution rate

Indexed keywords

ANTITHROMBIN; D DIMER; FIBRIN MONOMER; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; PLASMIN INHIBITOR; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRINMONOMER; HEMOSTATIC AGENT;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBOCYTE; THROMBOCYTE COUNT; BLOOD; DIAGNOSTIC USE; DISSEMINATED INTRAVASCULAR COAGULATION; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PHYSIOLOGY; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PLATELET COUNT; PROSPECTIVE STUDIES;

EID: 77953122371     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.03.017     Document Type: Article

References (28)

1. Mu{double acute}ller-Berghaus G. Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anti-coagulant pathways. Semi Thromb Hemost 15 (1989) 58-98
2. Levi M., de Jonge E., van der Poll T., and ten Cate H. Disseminated intravascular coagulation. Thromb Haemost 82 (1999) 695-705
3. Taylor Jr. F.B., Toh C.H., Hoots W.K., Wada H., and Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 86 (2001) 1327-1330
4. Wada H. Disseminated intravascular coagulation. Clin Chim Acta 344 (2004) 13-21
5. Warren B.L., Eid A., Singer P., Pillay S.S., Carl P., Novak I., et al. the KyberSept Trial Study Group: High-dose antithrombin in severe sepsis. A randomized controlled trial. JAMA 286 (2001) 1869-1878
6. Bernard G.R., Vincent J.L., Laterre P.F., Larosa S.P., Dhainaut J.F., Lopez-Rodriguez A., et al. Efficacy and safety of recombinant human protein C for severe sepsis. N Engl J Med 8 (2001) 699-709
7. Abraham E., Reinhart K., Opal S., Demeyer I., Doig C., Rodriguez A.L., et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290 (2003) 238-247
8. Kobayashi N., Maegawa T., Takada M., Tanaka H., and Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haemotol 49 (1983) 265-275
9. Gando S., Iba T., Eguchi Y., Ohtomo Y., Okamoto K., Koseki K., et al. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study GroupA multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34 (2006) 625-631
10. Wada H., Wakita Y., Nakase T., Shimura M., Hiyoyama K., Nagaya S., et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 74 (1995) 848-852
11. Toh C.H., and Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 16 (2005) 69-74
12. Hayakawa M., Gando S., and Hoshino H. A Prospective comparison of new Japanese criteria for disseminated intravascular coagulation: new Japanese criteria versus ISTH criteria. Clin Appl Thromb Hemost 13 (2007) 172-181
13. Egi M., Morimatsu H., Wiedermann C.J., Tani M., Kanazawa T., Suzuki S., et al. Non-overt disseminated intravascular coagulation scoring for critically ill patients: The impact of antithrombin levels. Thromb Haemost 101 (2009) 696-705
14. Toh C.H., and Hoots W.K. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 5 (2007) 604-606
15. Wada H., Gabazza E.C., Nakasaki T., Shimura M., Hiyoyama K., Deguchi K., et al. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers. Semin Thromb Hemost 26 (2000) 17-22
16. Wada H., Sakuragawa N., and Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost 24 (1998) 293-297
17. Solano C., Lamuño M., Vargas A., and Amezcua-Guerra L.M. Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome. Clin Exp Rheumatol 27 (2009) 914-919
18. Vincent J.L., Moreno R., and Takahara J. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intens Care Med 22 (1996) 707-710
19. Bone R.C. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268 (1992) 3452-3455
20. Gando S., Kameue T., Nanzaki S., and Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 75 (1996) 224-228
21. Wada H., Yamamuro M., Inoue A., Shiku H., Sakuragawa N., Redl H., et al. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. coli sepsis - Toward a distinct between uncompensated overt DIC and compensated non-overt DIC. Thromb Haemost 86 (2001) 1489-1494
22. Asakura H., Ontachi Y., Mizutani T., Kato M., Ito T., Saito M., et al. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Eur J Haematol 67 (2001) 170-175
23. Ruf W., and Riewald M. Tissue factor-dependent coagulation protease signaling in acute lung injury. Crit Care Med 31 (2003) S231-S237
24. Mosnier L.O., Zlokovic B.V., and Griffin J.H. The cytoprotective protein C pathway. Blood 109 (2007) 3161-3172
25. de Meis E., Pinheiro V.R., Zamboni M.M., Guedes M.T., Castilho I.A., Martinez M.M., et al. Clotting, immune system, and venous thrombosis in lung adenocarcinoma patients: a prospective study. Cancer Invest 27 (2009) 989-997
26. Miesbach W., Asherson R.A., Cervera R., and Shoenfeld Y. Gomez Puerta J, Bucciarelli S, Espinoza G, Font J; Members of CAPS Registry Group: The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev 6 (2006) 94-97
27. Kinasewitz G.T., Zein J.G., Lee G.L., Nazir S.A., and Taylor Jr. F.B. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis. Crit Care Med 33 (2005) 2214-2221
28. Wada H., Mori Y., Shimura M., Hiyoyama K., Nakasaki T., Ioka M., et al. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. Am J Heamtol 58 (1998) 189-194